{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T20:04:14Z","timestamp":1773173054743,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.thromres.2017.06.029","type":"journal-article","created":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:18:06Z","timestamp":1498324686000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A case that illustrates the challenges of managing pregnant patients with antithrombin deficiency: More questions than answers"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5587-398X","authenticated-orcid":false,"given":"Leslie","family":"Skeith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5043-0557","authenticated-orcid":false,"given":"Andrew","family":"Aw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4949-1459","authenticated-orcid":false,"given":"Julia","family":"Hews-Girard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Rydz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2017.06.029_bb0005","first-page":"7","article-title":"Case report management of venous thromboembolism in patients with hereditary Antithrombin deficiency and pregnancy: case report and review of the literature","volume":"2017","author":"Refaei","year":"2017","journal-title":"Case Rep. Hematol."},{"key":"10.1016\/j.thromres.2017.06.029_bb0010","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/j.1365-2516.2008.01830.x","article-title":"Inherited antithrombin deficiency: a review","volume":"14","author":"Patnaik","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2017.06.029_bb0015","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1182\/asheducation-2011.1.150","article-title":"Is thrombophilia testing useful?","volume":"2011","author":"Middeldorp","year":"2011","journal-title":"Hematology"},{"key":"10.1016\/j.thromres.2017.06.029_bb0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11239-015-1309-0","article-title":"Guidance for the treatment and prevention of obstetric-associated venous thromboembolism","volume":"41","author":"Bates","year":"2016","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2017.06.029_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review","volume":"132","author":"Robertson","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2017.06.029_bb0030","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-125-12-199612150-00003","article-title":"Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis","volume":"125","author":"Friederich","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2017.06.029_bb0035","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1538-7836.2010.03840.x","article-title":"A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin","volume":"8","author":"Mahmoodi","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.06.029_bb0040","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1182\/blood-2016-03-703728","article-title":"Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium","volume":"128","author":"Gerhardt","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2017.06.029_bb0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.thromres.2016.01.018","article-title":"Pregnancy related stroke in the setting of homozygous type-II HBS antithrombin deficiency","volume":"139","author":"Kovac","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2017.06.029_bb0050","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(09)60996-X","article-title":"Pulmonary embolism in pregnancy","volume":"375","author":"Bourjeily","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2017.06.029_bb0055","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2017.06.029_bb0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1701-2163(15)30569-7","article-title":"Venous thromboembolism and antithrombotic therapy in pregnancy","volume":"36","author":"Chan","year":"2014","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.thromres.2017.06.029_bb0065","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood.V87.9.3531.bloodjournal8793531","article-title":"Inherited thrombophilia: pathogenesis, clinical syndromes, and management","volume":"87","author":"De Stefano","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2017.06.029_bb0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-9560-12-12","article-title":"Management of pregnancy associated venous-thromboembolism: a survey of practices","volume":"12","author":"G\u00e1ndara","year":"2014","journal-title":"Thromb. J."},{"key":"10.1016\/j.thromres.2017.06.029_bb0075","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1160\/TH07-04-0282","article-title":"Successful outcome in a pregnant woman with homozygous antithrombin deficiency","volume":"98","author":"Alguel","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.06.029_bb0080","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ajh.22222","article-title":"Test of the month: the chromogenic antifactor Xa assay","volume":"87","author":"Gehrie","year":"2012","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2017.06.029_bb0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.thromres.2006.10.006","article-title":"Monitoring unfractionated heparin (UFH) therapy: which anti factor Xa assay is appropriate?","volume":"120","author":"Ignjatovic","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2017.06.029_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/4054806","article-title":"Clinical scenarios for discordant anti-Xa","volume":"2016","author":"Vera-Aguilera","year":"2016","journal-title":"Adv. Hematol."},{"key":"10.1016\/j.thromres.2017.06.029_bb0095","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1160\/TH13-01-0077","article-title":"How I treat heterozygous hereditary antithrombin deficiency in pregnancy","volume":"110","author":"Bramham","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.06.029_bb0100","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/MBC.0000000000000348","article-title":"Management and outcome of pregnancies in women with antithrombin deficiency: a single-center experience and review of literature","volume":"26","author":"Ilonczai","year":"2015","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2017.06.029_bb0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00277-013-1892-0","article-title":"Prevention, management and extent of adverse pregnancy outcomes in women with hereditary antithrombin deficiency","volume":"93","author":"Rogenhofer","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.thromres.2017.06.029_bb0110","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/MBC.0000000000000076","article-title":"Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapy","volume":"25","author":"Paidas","year":"2014","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2017.06.029_bb0115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/IJWH.S43190","article-title":"Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency","volume":"5","author":"James","year":"2013","journal-title":"Int. J. Women's Health"},{"key":"10.1016\/j.thromres.2017.06.029_bb0120","first-page":"1","article-title":"Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism","author":"Bhutia","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.thromres.2017.06.029_bb0125","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/clpt.2008.73","article-title":"Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy","volume":"84","author":"Lebaudy","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2017.06.029_bb0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tmrv.2010.08.007","article-title":"Cerebral venous thrombosis during pregnancy in the setting of type I Antithrombin deficiency: case report and literature review","volume":"25","author":"Sharpe","year":"2011","journal-title":"Transfus. Med. Rev."},{"key":"10.1016\/j.thromres.2017.06.029_bb0135","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1055\/s-0038-1646334","article-title":"Treatment of venous thromboembolism in patients with congenital deficiency of antithrombin III","volume":"68","author":"Schulman","year":"1992","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.06.029_bb0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0028-2243(84)90013-3","article-title":"Prophylaxis of thrombosis in antithrombin III-deficient women during pregnancy and delivery","volume":"18","author":"Michiels","year":"1984","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.thromres.2017.06.029_bb0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2141.1984.tb03952.x","article-title":"Management of planned pregnancy in a patient with congenital antithrombin III deficiency","volume":"56","author":"Samson","year":"1984","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2017.06.029_bb0150","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.thromres.2016.05.011","article-title":"First case with antithrombin deficiency, mesenteric vein thrombosis and pregnancy: multidisciplinary diagnosis and successful management","volume":"144","author":"Garcia-Botella","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2017.06.029_bb0155","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ajh.2830390118","article-title":"Letter to the editor: prophylaxis of thromboembolism during pregnancy in hereditary AT-III deficiency","volume":"39","author":"Brenner","year":"1992","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2017.06.029_bb0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.160.2.191","article-title":"Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature","volume":"160","author":"Chan","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2017.06.029_bb0165","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1160\/TH06-02-0108","article-title":"Vitamin K antagonists and pregnancy outcome","volume":"95","author":"Schaefer","year":"2006","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.06.029_bb0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/MBC.0b013e3283646620","article-title":"A new case of successful outcome of pregnancy in a carrier of homozygous type II (L99F) antithrombin deficiency","volume":"25","author":"Pascual","year":"2014","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2017.06.029_bb0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1447-0756.2001.tb01250.x","article-title":"Management of pregnancy with congenital antithrombin III deficiency: two case reports and a review of the literature","volume":"27","author":"Yamada","year":"2001","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.thromres.2017.06.029_bb0180","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0049-3848(92)90305-T","article-title":"Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes","volume":"66","author":"Kario","year":"1992","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2017.06.029_bb0185","first-page":"147","article-title":"Effective prophylaxis of thrombosis by antithrombin III concentrate in a pregnant women with congenital antithrombin III deficiency: relations between plasma antithrombin III activity and the plasma levels of hemostatic molecular markers.pdf","volume":"21","author":"Inomoto","year":"1991","journal-title":"Haemostasis"},{"key":"10.1016\/j.thromres.2017.06.029_bb0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000299460","article-title":"Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin","volume":"14","author":"Hellgren","year":"1982","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.thromres.2017.06.029_bb0195","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-0038-1642752","article-title":"Management of pregnancy in women with antithrombin III congenital defect: report of four cases","volume":"59","author":"De Stefano","year":"1988","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.06.029_bb0200","first-page":"343","article-title":"Recombinant human Antithrombin in pregnant patients with hereditary Antithrombin deficiency: integrated analysis of clinical data","volume":"33","author":"Michael","year":"2016","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.thromres.2017.06.029_bb0205","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2147\/IJWH.S52208","article-title":"Use of recombinant human antithrombin concentrate in pregnancy","volume":"5","author":"Kreuziger","year":"2013","journal-title":"Int. J. Womens Health"},{"key":"10.1016\/j.thromres.2017.06.029_bb0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0049-3848(92)90239-7","article-title":"The pregnant antithrombin III deficient patient: management without antithrombin III concentrate","volume":"65","author":"Blondel-Hill","year":"1992","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2017.06.029_bb0215","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/jth.13353","article-title":"Examining the transplacental passage of apixaban using the dually perfused human placenta","volume":"14","author":"Bapat","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.06.029_bb0220","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/AOG.0000000000000277","article-title":"Transfer of dabigatran and dabigatran Etexilate Mesylate across the dually perfused human placenta","volume":"123","author":"Bapat","year":"2014","journal-title":"Obstet. Gynecol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817303936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817303936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T21:34:22Z","timestamp":1602365662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384817303936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":44,"alternative-id":["S0049384817303936"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2017.06.029","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case that illustrates the challenges of managing pregnant patients with antithrombin deficiency: More questions than answers","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2017.06.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}